RAVELLI, COSETTA
 Distribuzione geografica
Continente #
NA - Nord America 4.998
EU - Europa 3.269
AS - Asia 2.678
SA - Sud America 453
Continente sconosciuto - Info sul continente non disponibili 174
AF - Africa 63
OC - Oceania 18
Totale 11.653
Nazione #
US - Stati Uniti d'America 4.855
PL - Polonia 1.225
SG - Singapore 902
CN - Cina 805
IT - Italia 674
BR - Brasile 358
HK - Hong Kong 283
UA - Ucraina 269
DE - Germania 257
VN - Vietnam 217
FI - Finlandia 178
GB - Regno Unito 157
FR - Francia 138
IN - India 101
BD - Bangladesh 81
TR - Turchia 80
CA - Canada 74
RU - Federazione Russa 73
IE - Irlanda 65
NL - Olanda 41
ID - Indonesia 40
AR - Argentina 38
BE - Belgio 35
ES - Italia 35
JP - Giappone 30
MX - Messico 30
ZA - Sudafrica 29
SE - Svezia 28
CZ - Repubblica Ceca 24
IQ - Iraq 21
EC - Ecuador 20
AT - Austria 17
PK - Pakistan 14
AE - Emirati Arabi Uniti 13
AU - Australia 11
JM - Giamaica 11
MY - Malesia 11
PH - Filippine 11
CO - Colombia 10
VE - Venezuela 10
SA - Arabia Saudita 9
NG - Nigeria 8
UZ - Uzbekistan 8
CH - Svizzera 7
EE - Estonia 7
EG - Egitto 7
GR - Grecia 7
HN - Honduras 7
KR - Corea 7
AL - Albania 6
CL - Cile 6
KE - Kenya 6
NZ - Nuova Zelanda 6
TH - Thailandia 6
IR - Iran 5
KZ - Kazakistan 5
DO - Repubblica Dominicana 4
ET - Etiopia 4
GT - Guatemala 4
IL - Israele 4
MA - Marocco 4
OM - Oman 4
PE - Perù 4
AZ - Azerbaigian 3
BG - Bulgaria 3
CR - Costa Rica 3
DZ - Algeria 3
HU - Ungheria 3
KG - Kirghizistan 3
PA - Panama 3
PY - Paraguay 3
RO - Romania 3
UY - Uruguay 3
BY - Bielorussia 2
CY - Cipro 2
EU - Europa 2
JO - Giordania 2
LA - Repubblica Popolare Democratica del Laos 2
LT - Lituania 2
LV - Lettonia 2
NO - Norvegia 2
TT - Trinidad e Tobago 2
AG - Antigua e Barbuda 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BZ - Belize 1
DK - Danimarca 1
FJ - Figi 1
GD - Grenada 1
GE - Georgia 1
HR - Croazia 1
IS - Islanda 1
MD - Moldavia 1
MK - Macedonia 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
MT - Malta 1
Totale 11.472
Città #
Warsaw 1.218
Ashburn 549
Singapore 475
San Jose 345
Fairfield 310
Hong Kong 279
Brescia 268
Jacksonville 215
Woodbridge 192
Ann Arbor 190
Council Bluffs 181
Chandler 180
Beijing 168
Seattle 136
The Dalles 134
Houston 129
New York 124
Wilmington 123
Los Angeles 116
Princeton 114
Cambridge 111
Helsinki 103
Dearborn 100
Dallas 97
Milan 80
Munich 73
Dong Ket 63
Istanbul 63
Nanjing 63
Lauterbourg 60
Dublin 59
Ho Chi Minh City 55
Santa Clara 52
Columbus 51
Buffalo 42
São Paulo 40
Shanghai 39
San Francisco 36
Turku 35
Jakarta 34
Orem 33
Brussels 31
Hanoi 31
Shenyang 31
Chicago 29
London 28
Phoenix 28
Changsha 26
Nanchang 26
Atlanta 25
Moscow 25
Denver 24
Des Moines 24
Jinan 23
Madrid 23
Rome 22
San Diego 22
Guangzhou 21
Montreal 21
Tokyo 20
Toronto 20
Hebei 19
Chennai 18
Johannesburg 18
Nuremberg 18
Boston 17
Brooklyn 17
Amsterdam 16
Boardman 16
Lappeenranta 16
Frankfurt am Main 15
Las Vegas 14
Olomouc 14
Redondo Beach 14
Stockholm 14
Tianjin 13
Brasília 12
Haikou 12
Mexico City 12
Hangzhou 11
Augusta 10
Charlotte 10
Dhaka 10
Fara Gera d'Adda 10
Naples 10
Zhengzhou 10
Kunming 9
Lanzhou 9
Poplar 9
Washington 9
Hefei 8
Jiaxing 8
Kingston 8
Manchester 8
Paris 8
Romola 8
Abuja 7
Ankara 7
Baghdad 7
Belo Horizonte 7
Totale 7.693
Nome #
A study on the VEGFR2-ligand multi-physics interactions in Angiogenesis. 328
Multi-physics interactions drive VEGFR2 relocation on endothelial cells. 311
Gremlin is a novel agonist of the major pro-angiogenic receptor VEGFR2 305
Claudin3 is localized outside the tight junctions in human carcinomas 303
Angiopoietin-1 mediates the pro-angiogenic activity of the bone morphogenic protein antagonist Drm 286
Modeling and Simulation of VEGF Receptors Recruitment in Angiogenesis 286
Heparan Sulfate Proteoglycans Mediate the Angiogenic Activity of the Vascular Endothelial Growth Factor Receptor-2 Agonist Gremlin. 285
Monomeric gremlin is a novel vascular endothelial growth factor receptor-2 antagonist 284
β3 Integrin promotes long-lasting activation and polarization of vascular endothelial growth factor receptor 2 by immobilized ligand 276
Involvement of α(v)β (3) integrin in gremlin-induced angiogenesis. 259
Cyclic adenosine monophosphate-response element-binding protein mediates the proangiogenic or proinflammatory activity of gremlin. 236
Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of HIV-1 Tat and gp120 proteins 233
Long pentraxin-3 inhibits epithelial-mesenchymal transition in melanoma cells. 208
Natural Histogel-Based Bio-Scaffolds for Sustaining Angiogenesis in Beige Adipose Tissue 204
A novel pro-oncogenic mutated form of VEGFR2 modulates the activity of co-expressed wild-type receptor in melanoma 203
3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy 196
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE MORPHOGENIC PROTEIN ANTAGONIST DRM 194
A Model of Integrin and VEGF Receptors Recruitment on Endothelial Cells 192
ANGIOPOIETIN-1 MEDIATES THE PRO-ANGIOGENIC ACTIVITY OF THE BONE-MORPHOGENIC PROTEIN ANTAGONIST DRM 190
Co-designed experiments and multi-physics modeling of the VEGFR-2 relocation on endothelial cells. 188
Role of Nanomechanics in Canonical and Noncanonical Pro-angiogenic Ligand/VEGF Receptor-2 Activation 182
VEGFR2(R1051Q) and FGFR1(D647N) correspondent mutations exhibit pro-oncogenic effects both in vitro and in vivo 174
A novel VEGFR2 mutation has oncogenic potential in BRAF wild type melanoma 173
Leucine-Rich Repeat Kinase-2 Controls the Differentiation and Maturation of Oligodendrocytes in Mice and Zebrafish 171
A novel variant of VEGFR2 identified by a pan-cancer screening of recurrent somatic mutations in the catalytic domain of tyrosine kinase receptors enhances tumor growth and metastasis 171
Hot spot mutation in receptor tyrosine kinases elicits pro-oncogenic effects 169
Insights on the receptor dynamics during the spreading of endothelial cells 165
Vascular disrupting activity of combretastatin analogues 154
Simulation of VEGF receptor recruitment on ECs membrane 151
A mechano-biological model of the coupling between cellular con- tractility and VEGFR2/VEGF interactions. 151
cAMP-response element-binding protein (CREB) mediates the pro-angiogenic/inflammatory activity of gremlin. 149
β-Galactosylceramidase Deficiency Causes Bone Marrow Vascular Defects in an Animal Model of Krabbe Disease 149
Role of VEGFs in metabolic disorders 146
A novel VEGFR2 mutation has oncogenic potential in BRAF wild-type melanoma 145
VEGFR2 activation mediates the pro-angiogenic activity of BMP4 139
Expression of activated VEGFR2 by R1051Q mutation alters the energy metabolism of Sk-Mel-31 melanoma cells by increasing glutamine dependence 139
Novel potential oncogenic and druggable mutations of FGFRs recur in the kinase domain across cancer types 133
In Situ DNA/Protein Interaction Assay to Visualize Transcriptional Factor Activation 132
Substrate-immobilized HIV-1 Tat drives VEGFR2/αvβ3 integrin complex formation and polarization in endothelial cells 129
Binding to PI(4,5)P2 is indispensable for secretion of B-cell clonogenic HIV-1 matrix protein p17 variants 129
endothelial cell adhesion to HIV-1 Tat: cross talk between integrin alphav beta3 and vascular endothelial growth factor receptor-2 (KDR) 124
Role of VEGFR2 co-receptors in the modulation of the pro-angiogenic activity of gremlin. 124
Modeling cell motility and receptor dynamics 120
Heparan-sulfate proteoglycans mediate the angiogenic activity of the novel VEGFR2 agonist gremlin 119
VEGFR2 recruitment and activation by substratum-immobilized gremlin 118
Pentraxin 3 inhibits the angiogenic potential of multiple myeloma cells 116
Role of gremlin-1 in the pathophysiology of the adipose tissues 115
Identification and characterization of pro-oncogenic low frequency VEGFR2 mutations 113
Glyco-Coated CdSe/ZnS Quantum Dots as Nanoprobes for Carbonic Anhydrase IX Imaging in Cancer Cells 113
Flk-1/KDR and v3 recruitment and cross-talk at the basal aspect of HIV-1 Tat-adherent endothelial cells drives pp60src/ERK1/2 activation, cytoskeleton organization and pro-angiogenic activation 112
The expression level of VEGFR2 regulates mechanotransduction, tumor growth and metastasis of high grade serous ovarian cancer cells 111
THE CYSTINE-KNOT PROTEIN GREMLIN IS A NOVEL AGONIST OF THE MAJOR PRO-ANGIOGENIC RECEPTOR VEGFR2 109
Fluorolabeling of the PPTase-Related Chemical Tags: Comparative Study of Different Membrane Receptors and Different Fluorophores in the Labeling Reactions 107
Mechanobiology of the relocation of proteins in advecting cells: in vitro experiments, multi-physics modeling, and simulations 106
VEGFR2 and v3 recruitment and cross-talk at the basal aspect of HIV-1 Tat-adherent endothelial cells drives pp60src/ERK1/2 activation, cytoskeleton organization and pro-angiogenic activation 106
VEGFR2 recruitment and activation by substrate-immobilized VEGF 106
VEGFR2 RECRUITMENT AND ACTIVATION BY SUBSTRATE-IMMOBILIZED DRM/GREMLIN 105
FGF-trapping hampers cancer stem-like cells in uveal melanoma 102
Alternative method to visualize receptor dynamics in cell membranes 102
Protein domain-based approaches for the identification and prioritization of therapeutically actionable cancer variants 101
The D647N mutation of FGFR1 induces ligand-independent receptor activation 98
The contribution of obesogenic behavior on global warming 98
Molecular insight on the altered membrane trafficking of TrkA kinase dead mutants 98
Deficiency of AP1 Complex Ap1g1 in Zebrafish Model Led to Perturbation of Neurodevelopment, Female and Male Fertility; New Insight to Understand Adaptinopathies 96
Specific targeting of the KRAS mutational landscape in myeloma as a tool to unveil the elicited anti-tumor activity 96
Irisin regulates thermogenesis and lipolysis in 3T3-L1 adipocytes 94
The Extracellular Matrix modulates mechanotransduction and metabolic alteration in EC leading to melanoma vascularization 90
Brain accumulation of lactosylceramide characterizes GALC deficiency in a zebrafish model of Krabbe disease 90
Mutation in the Kinase Domain Alters the VEGFR2 Membrane Dynamics 90
Cancer-associated VEGFR2R1032Q sustains receptor activation also by promoting ligand-independent hetero-dimerization with co-expressed wild-type VEGFR2 and translocation into lipid rafts 84
Two-Photon Microscopy for the Investigation of Morphological and Quantitative Changes in Skin Chrono- and Photo-Aging 83
The D405N Mutation in the Spike Protein of SARS-CoV-2 Omicron BA.5 Inhibits Spike/Integrins Interaction and Viral Infection of Human Lung Microvascular Endothelial Cells 81
Simultaneously characterization of tumoral angiogenesis and vasculogenesis in stem cell-derived teratomas 79
Production and Biochemical Characterization of Dimeric Recombinant Gremlin-1 75
The impact of adipokines on vascular networks in adipose tissue 53
A Glucosylated BODIPY Uses the GLUT Channel to Target Cancer Cells in In Vitro and In Vivo Models 49
Aberrant VEGFR2 supports tumor growth by extracellular matrix remodeling 34
The Metastatic Capacity of Melanoma Reveals Alternative Pathways of Cancer Dissemination 18
Totale 11.653
Categoria #
all - tutte 49.148
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.148


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022420 0 0 0 10 23 42 33 38 41 77 35 121
2022/2023555 82 45 27 29 50 111 13 58 76 9 23 32
2023/2024769 44 33 70 65 56 104 28 63 127 47 19 113
2024/20251.740 46 13 30 266 172 118 153 85 210 112 322 213
2025/20263.541 338 364 241 484 376 243 567 140 216 329 177 66
2026/2027666 137 148 280 101 0 0 0 0 0 0 0 0
Totale 11.653